R
Ruibing Wang
Researcher at University of Macau
Publications - 242
Citations - 7974
Ruibing Wang is an academic researcher from University of Macau. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 41, co-authored 206 publications receiving 5128 citations. Previous affiliations of Ruibing Wang include Queen's University & Jilin University.
Papers
More filters
Journal ArticleDOI
Protein Assembly: Versatile Approaches to Construct Highly Ordered Nanostructures
TL;DR: This Review outlines recent advances in the field of protein assembly and summarizes several strategies, including biotechnological strategies, chemical strategies, and combinations of these approaches, for manipulating proteins to self-assemble into desired nanostructures.
Journal ArticleDOI
Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines
Cheng Gao,Qiaoxian Huang,Conghui Liu,Cheryl H. T. Kwong,Ludan Yue,Jian-Bo Wan,Simon Ming-Yuen Lee,Ruibing Wang +7 more
TL;DR: Comparison to macrophage internalized with ROS-responsive NPs, as a live-cell based drug delivery system for treatment of atherosclerosis, suggests that cell membrane coated drug delivery approach is likely more suitable for dealing with an inflammatory disease than the live- cell approach.
Journal ArticleDOI
Nanomedicine in action: an overview of cancer nanomedicine on the market and in clinical trials
TL;DR: This paper is intended to examine several nanomedicines for cancer therapeutics and/or diagnostics-related applications, to analyze the trend ofnanomedicine development, future opportunities, and challenges of this fast-growing area.
Journal ArticleDOI
Preparation of graphene oxide-manganese dioxide for highly efficient adsorption and separation of Th(IV)/U(VI).
TL;DR: Results displayed that the α-GOM2 may be utilized as an potential adsorbent for removing and separating Th(IV)/U(VI) ions from aqueous solutions.
Journal ArticleDOI
A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease
Qixiong Zhang,Hui Tao,Yongyao Lin,Ying Hu,Huijie An,Dinglin Zhang,Shibin Feng,Houyuan Hu,Ruibing Wang,Xiaohui Li,Jianxiang Zhang +10 more
TL;DR: By scavenging multiple components of ROS, Tpl/OxbCD NP may effectively reduce ulcerative colitis in mice, and it can be intensively developed as a translational nanomedicine for the management of IBD and other inflammatory diseases.